SIM
CASI

Sonora Investment Management’s CASI Pharmaceuticals CASI Stock Holding History

Sonora Investment Management’s Portfolio CASI Stock Details CASI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-330
Closed -$10K – 1678
2019
Q4 		$10K Hold
330
– – ﹤0.01% 1207
2019
Q3 		$11K Hold
330
– – ﹤0.01% 1127
2019
Q2 		$11K Hold
330
– – ﹤0.01% 1100
2019
Q1 		$9K Hold
330
– – ﹤0.01% 1093
2018
Q4 		$13K Buy
+330
New +$12.5K ﹤0.01% 761

Other funds holding CASI

IACGFIA
IDG-Accel China Growth Fund III Associates Hong Kong $31.2M AUM 2.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WSCM
Wellington Shields Capital Management New York $666M AUM 45.43% 1-Year Est. Return
WSC
Wellington Shields & Co New York $392M AUM 30.65% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Sonora Investment Management's CASI Position: Q1 2020 in Review

Sonora Investment Management sold out of CASI Pharmaceuticals (CASI) in Q1 2020, closing a stake of 330 shares — an estimated $10K sold.

Sonora Investment Management first reported a position in CASI in Q4 2018 and held it in 5 quarters. The position peaked at $13K in Q4 2018. 58 funds tracked by Wall St. Rank hold CASI as of Q1 2020.

  • Sonora Investment Management reported no remaining CASI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Sonora Investment Management sold 330 CASI Pharmaceuticals shares in Q1 2020, an estimated $10K.
  • Sonora Investment Management first reported a position in CASI Pharmaceuticals in Q4 2018 and held it in 5 quarters.
  • Sonora Investment Management's CASI Pharmaceuticals position peaked at $13K in Q4 2018.
  • 58 funds tracked by Wall St. Rank held CASI Pharmaceuticals as of Q1 2020.

Based on Sonora Investment Management's 13F filing for Q1 2020, filed 29 Apr 2020.